| Product Code: ETC5311287 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Malta continues to see a significant influx of pulmonary/respiratory drug delivery imports, with key exporting countries in 2024 being India, Israel, Ireland, Germany, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the impressive Compound Annual Growth Rate (CAGR) of 10.1% from 2020 to 2024 highlights sustained growth. The notable growth rate of 29.61% from 2023 to 2024 suggests a rapidly expanding market for these specialized pharmaceutical products in Malta.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 Malta Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2021 & 2031F |
3.6 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2021 & 2031F |
3.7 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Malta Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Malta |
4.2.2 Growing awareness about the importance of pulmonary drug delivery |
4.2.3 Technological advancements in drug delivery devices for respiratory conditions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Limited healthcare infrastructure and resources in Malta |
5 Malta Pulmonary/ Respiratory Drug Delivery Market Trends |
6 Malta Pulmonary/ Respiratory Drug Delivery Market Segmentations |
6.1 Malta Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2021-2031F |
6.2 Malta Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2021-2031F |
6.2.3 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2021-2031F |
6.3 Malta Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2021-2031F |
6.3.3 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2021-2031F |
6.3.4 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2021-2031F |
6.4 Malta Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2021-2031F |
6.4.3 Malta Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2021-2031F |
7 Malta Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 Malta Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 Malta Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 Malta Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Percentage of population diagnosed with respiratory diseases in Malta |
8.2 Adoption rate of pulmonary drug delivery devices in healthcare facilities |
8.3 Rate of investment in research and development for new respiratory drug delivery technologies |
9 Malta Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 Malta Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2021 & 2031F |
9.2 Malta Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2021 & 2031F |
9.3 Malta Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 Malta Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Malta Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 Malta Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 Malta Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |